| Application no. and date | 10700233.9 (espacenet) (Federated) (European Patent Register), 20100111 | | Patent/reg. no. and date | DK/EP 2389164, 20140813 | | Publication date | 20111130 | | Priority no. and date | US 145999 P, 20090121 | | EP pub. no. and date |
EP 2389164 20111130 | | Effective date | | | Applicant/owner | Gilead Pharmasset LLC, c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404, US | | Applicant ref. no. | P54396DK01 | | Inventor | Sandhu, Harpreet K., 73 Manger Road
West Orange,
New Jersey 07052, US,
Shah, Navnit Hargovindas, 203 Beverly Hill Road
Clifton,
New Jersey 07012, US,
CHATTERJI, Ashish, 7 Prescott Road
East Brunswick, New Jersey 08816, US,
DESAI, Dipen, 202 Altaview Court
Whippany, New Jersey 07981, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/513 (2006.01) , A61K 9/20 (2006.01) | | Title | FARMACEUTISKE SAMMENSÆTNINGER OMFATTENDE ET HCV POLYMERASE INHIBITOR PRO-DRUG | | Int. application no. | EP2010050182 | | Int. publication no. | WO2010084041 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
